I am 28 and newly diagnosed with CML (a little over a week ago). I haven't begun Gleevec yet because my WBC is still very elevated and my oncologist thinks it's better to let the hydrea and allopurinol do the work until that WBC level is lower. On Thursday, I was finally down from 200k at dx to 113k.
My question is, I have been told that there is a minority of people who are not responsive or become resistant to Gleevec and I am trying to find out what that statistic is. I thought my doctor told me 60% of people respond well to gleevec and 40% of other people try drug b or c and then a very small amount of people go the transplant route, but that concersation is very foggy. I have a second opinion with a CML specialist coming up and know I will be getting better information than I have gotten thus far. Until then, I am trying to figure out the stats on just how many people respond well to gleevec and what the current percentage of people needing to go the transplant route is. I keep seeing th 90% 5 year survival rate for people on Gleevec, but wasn't sure if that 90% includes all people dx'ed with CML and starting Gleevec or is it 90% of people who have proven an original good response to gleevec and are not resistant to it have the 5 year survival rate?
I'm very much in the "over-analyzing" stage, so if I'm just getting too analytical, let me know! I hope I explained my question well enough.
Thanks!










